Reference health
Substrate Stiffness Modulates the Growth, Phenotype, and Chemoresistance of Ovarian Cancer Cells
1 of 71 checkable references need attention · checked 2026-07-22
At the dated check, the references listed below either did not resolve in Crossref or DataCite, or carried a retraction notice. Each one is shown with the registry record that put it there.
3 without a DOI — not checked. A reference deposited without a DOI is never matched by title or guessed at; it stays outside the checked set, and this line discloses that.
References needing attention
does not resolve to a known work10.1126/science.aaaa4559
The 70 checked references that resolve
resolves10.1016/j.cell.2013.07.042
A Mechanical Checkpoint Controls Multicellular Growth through YAP/TAZ Regulation by Actin-Processing Factors
resolves10.1038/ncb1037
Sphingosylphosphorylcholine regulates keratin network architecture and visco-elastic properties of human cancer cells
resolves10.1016/j.drup.2012.01.006
The tumor microenvironment is a dominant force in multidrug resistance
resolves10.18632/oncotarget.13817
The involvement of Bcl-2 family proteins in AKT-regulated cell survival in cisplatin resistant epithelial ovarian cancer
resolves10.1016/j.lungcan.2004.01.008
Irinotecan and docetaxel as first line chemotherapy in patients with stage IIIB/IV non-small cell lung cancer—experience from a prematurely closed phase II study
resolves10.1038/nrgastro.2012.115
The role of stroma in pancreatic cancer: diagnostic and therapeutic implications
resolves10.2147/ott.S109979
Verteporfin, a suppressor of YAP–TEAD complex, presents promising antitumor properties on ovarian cancer
resolves10.3233/Ch-131696
Substrate stiffness influences the outcome of antitumor drug screening in vitro
resolves10.3892/mmr.2017.6960
KDM5A promotes proliferation and EMT in ovarian cancer and closely correlates with PTX resistance
resolves10.3390/cancers3011351
Cisplatin as an Anti-Tumor Drug: Cellular Mechanisms of Activity, Drug Resistance and Induced Side Effects
resolves10.1002/ijc.23086
Akt promotes cisplatin resistance in human ovarian cancer cells through inhibition of p53 phosphorylation and nuclear function
resolves10.3389/fgene.2020.00516
MDR1 Gene Polymorphisms and Its Association With Expression as a Clinical Relevance in Terms of Response to Chemotherapy and Prognosis in Ovarian Cancer
resolves10.1002/1878-0261.12414
Targeting <scp>HER</scp>2 in patient‐derived xenograft ovarian cancer models sensitizes tumors to chemotherapy
resolves10.1111/j.1365-2141.2006.06435.x
<i>β</i>1 integrin mediated adhesion increases Bim protein degradation and contributes to drug resistance in leukaemia cells
resolves10.1038/sj.onc.1203782
Adhesion to fibronectin via β1 integrins regulates p27kip1 levels and contributes to cell adhesion mediated drug resistance (CAM-DR)
resolves10.1016/j.cell.2005.06.007
The Hippo Signaling Pathway Coordinately Regulates Cell Proliferation and Apoptosis by Inactivating Yorkie, the Drosophila Homolog of YAP
resolves10.3892/ijo.2017.3877
Matrix stiffness regulates the proliferation, stemness and chemoresistance of laryngeal squamous cancer cells
resolves10.1016/j.biopha.2013.09.004
Expression of MDR1 and MDR3 gene products in paclitaxel-, doxorubicin- and vincristine-resistant cell lines
resolves10.1016/0005-2736(76)90160-7
A surface glycoprotein modulating drug permeability in Chinese hamster ovary cell mutants
resolves10.3892/ijo.31.2.277
Chemoresistance to paclitaxel induces epithelial-mesenchymal transition and enhances metastatic potential for epithelial ovarian carcinoma cells
resolves10.1006/gyno.2002.6738
Multidrug Resistance Gene-1 Is a Useful Predictor of Paclitaxel-Based Chemotherapy for Patients with Ovarian Cancer
resolves10.1016/j.bbamcr.2017.11.012
Soft drug-resistant ovarian cancer cells migrate via two distinct mechanisms utilizing myosin II-based contractility
resolves10.1016/s0009-9120(99)00026-0
Increased bcl-2 expression is associated with primary resistance to chemotherapy in human epithelial ovarian cancer
resolves10.1186/1475-2867-14-41
The role of cancer-associated fibroblasts, solid stress and other microenvironmental factors in tumor progression and therapy resistance
resolves10.1038/sj.onc.1206315
Cell adhesion-mediated drug resistance (CAM-DR) is associated with activation of NF-κB (RelB/p50) in myeloma cells
resolves10.1016/j.cell.2009.10.027
Matrix Crosslinking Forces Tumor Progression by Enhancing Integrin Signaling
resolves10.1002/bab.1302
Role of three‐dimensional matrix stiffness in regulating the chemoresistance of hepatocellular carcinoma cells
resolves10.1002/smll.201601365
Porous Matrix Stiffness Modulates Response to Targeted Therapy in Breast Carcinoma
resolves10.1101/gad.192856.112
Genetic and pharmacological disruption of the TEAD–YAP complex suppresses the oncogenic activity of YAP
resolves10.3390/cancers11060838
The Role of Epithelial-to-Mesenchymal Plasticity in Ovarian Cancer Progression and Therapy Resistance
resolves10.1038/s41598-018-25589-0
The mechanical microenvironment regulates ovarian cancer cell morphology, migration, and spheroid disaggregation
resolves10.1038/nm.2492
Adipocytes promote ovarian cancer metastasis and provide energy for rapid tumor growth
resolves10.15430/JCP.2016.21.2.73
Nano-mechanical Phenotype as a Promising Biomarker to Evaluate Cancer Development, Progression, and Anti-cancer Drug Efficacy
resolves10.1371/journal.pone.0126107
An Atomic Force Microscope Study Revealed Two Mechanisms in the Effect of Anticancer Drugs on Rate-Dependent Young’s Modulus of Human Prostate Cancer Cells
resolves10.1038/oncsis.2017.54
Matrix stiffness induces epithelial–mesenchymal transition and promotes chemoresistance in pancreatic cancer cells
resolves10.1002/hep.24108
Matrix stiffness modulates proliferation, chemotherapeutic response, and dormancy in hepatocellular carcinoma cells
resolves10.1038/9511
Extracellular matrix proteins protect small cell lung cancer cells against apoptosis: A mechanism for small cell lung cancer growth and drug resistance in vivo
resolves10.1039/c3ib40246k
The role of Rho GTPase in cell stiffness and cisplatin resistance in ovarian cancer cells
resolves10.2741/e161
AFM and fluorescence imaging of nanomechanical response in periodontal ligament cells
resolves10.1073/pnas.1004900107
Core epithelial-to-mesenchymal transition interactome gene-expression signature is associated with claudin-low and metaplastic breast cancer subtypes
resolves10.1158/0008-5472.CAN-05-0616
Carcinoma Invasion and Metastasis: A Role for Epithelial-Mesenchymal Transition?
resolves10.1371/journal.pone.0012905
Matrix Rigidity Regulates Cancer Cell Growth and Cellular Phenotype
resolves10.1038/ncomms15206
YAP/TAZ link cell mechanics to Notch signalling to control epidermal stem cell fate
resolves10.1016/0959-8049(94)90132-5
Expression of P-glycoprotein and in vitro or in vivo resistance to doxorubicin and cisplatin in breast and ovarian cancers
resolves10.1002/cncr.29321
<scp>S</scp>ociety of <scp>G</scp>ynecologic <scp>O</scp>ncology recommendations for the prevention of ovarian cancer
resolves10.1002/sca.1998.4950200504
Mechanical properties of L929 cells measured by atomic force microscopy: Effects of anticytoskeletal drugs and membrane crosslinking
resolves10.3389/fcell.2021.641469
Adaptive Mechanisms of Tumor Therapy Resistance Driven by Tumor Microenvironment
resolves10.1371/journal.pone.0046609
Cell Stiffness Is a Biomarker of the Metastatic Potential of Ovarian Cancer Cells
resolves10.1016/j.cell.2004.06.006
Twist, a Master Regulator of Morphogenesis, Plays an Essential Role in Tumor Metastasis
resolves10.1038/bjc.2014.136
Acquisition of epithelial–mesenchymal transition is associated with Skp2 expression in paclitaxel-resistant breast cancer cells
resolves10.1158/0008-5472.Can-05-0425
Akt-Mediated Cisplatin Resistance in Ovarian Cancer: Modulation of p53 Action on Caspase-Dependent Mitochondrial Death Pathway
resolves10.1016/j.biopha.2018.07.059
MiR-1294 confers cisplatin resistance in ovarian Cancer cells by targeting IGF1R
resolves10.1101/gad.173435.111
Cell detachment activates the Hippo pathway via cytoskeleton reorganization to induce anoikis
The 3 references without a DOI — listed, not checked
no DOI — not checkedExpression of a human multidrug resistance gene in ovarian carcinomas.
no DOI — not checkedMiR-181a upregulation is associated with epithelial-To-mesenchymal transition (EMT) and multidrug resistance (MDR) of ovarian cancer cells.
no DOI — not checkedExpression of twist and wnt in human breast cancer.
What this badge says. CiteStamped means the CHECKABLE references of this
work were clean at the dated check: each resolved to a known work in a public registry, and none
carried a retraction notice at that time. It says nothing about the quality, findings,
or importance of the work itself, and nothing about references deposited without a DOI.
checked 2026-07-22 — re-checked daily as this page is visited; titles and statuses come from Crossref and DataCite and are not part of the signed record
Embed this badge
Both snippets point at the live badge image and link back to this page. The badge re-renders from the daily check, so an embed never goes stale by more than a day of visits.
<a href="https://citestamp.com/citestamped/10.3389/fcell.2021.718834"><img src="https://citestamp.com/citestamped/10.3389/fcell.2021.718834/badge.svg" alt="CiteStamped reference-health badge" width="460" height="64"></a>
[](https://citestamp.com/citestamped/10.3389/fcell.2021.718834)